Dichlorphenamide    (DrugBank: Dichlorphenamide)

1 disease
IDDisease name (Link within this page)Number of trials
114Non-dystrophic myotonia syndrome1

114. Non-dystrophic myotonia syndrome    [ 10 clinical trials,   14 drugs,   (DrugBank: 5 drugs),   18 drug target genes,   10 drug target pathways]
Searched query = "Non-dystrophic myotonia syndrome", "Non-dystrophic Myotonia", "Myotonia congenita", "Thomsen disease", "Becker disease", "Paramyotonia congenita", "Sodium channel myotonia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 10 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00004802
(ClinicalTrials.gov)
June 199224/2/2000Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel DisordersParalysis, Hyperkalemic Periodic;Hypokalemic Periodic Paralysis;Paramyotonia CongenitaDrug: dichlorphenamideNational Center for Research Resources (NCRR)Ohio State UniversityCompleted10 Years75 YearsBoth64Phase 3NULL